Sandra Patterson - 10 Mar 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: SVP, Controllership
Signature: /s/ Edward S. Son by Power of Attorney for Sandra C. Patterson
Issuer symbol: GILD
Transactions as of: 10 Mar 2025
Net transactions value: -$73,139
Form type: 4
Filing time: 12 Mar 2025, 18:10:09 UTC
Previous filing: 06 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+1,952	+5.1%		40,077	10 Mar 2025	Direct	F1
transaction	GILD	Common Stock	Tax liability	$73,139	-624	-1.6%	$117.21	39,453	10 Mar 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-1,952	-17%		9,875	10 Mar 2025	Common Stock	1,952		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
F3	The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.